
Otezla: An oral pill for plaque psoriasis, psoriatic arthritis and the mouth ulcers of Behcet's disease. It needs no routine blood tests, and it is gentler and less powerful than the injected treatments. Zoryve: A once-daily steroid-free cream for psoriasis, eczema and seborrheic dermatitis. It has no boxed warning and no limit on how long or how much you use it, which is unusual.


Choose for moderate psoriasis or psoriatic arthritis when you want a pill with no routine blood tests, accepting it's gentler than injections.
Choose for psoriasis, eczema or seborrheic dermatitis when you want a once-daily non-steroid with no limit on time or area.
Can you take them together?
Zoryve can be used on remaining plaques while taking Otezla. Both work through the same pathway, but the cream acts only on the skin.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.











Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Psoriasis plaques become less inflamed.
PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.

Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Redness, scaling, and itch can improve.
PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.
Nothing about the dose depends on weight or on how severe your disease is. It is built up gradually only to give your stomach time to settle.
Starting dose: A five-day starter pack, beginning at 10 mg on day one and climbing in 10 mg steps, morning and evening doses in turn, until you reach 30 mg twice a day on day six.
Usual dose: 30 mg twice a day, about 12 hours apart.
If your kidneys are significantly impaired: The dose is halved to 30 mg once a day, and the starter pack is used differently.
Total course: No fixed course. It is taken as long as it helps, judged at about 16 weeks, and the benefit stops when the drug stops.
When to Apply: Once a day, at a time you will remember. A thin layer over the affected skin, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts. Moisturizer and sunscreen can go on top once it has absorbed. For the foam, part the hair and apply to the scalp rather than the hair.
How to Start: Once daily from day one, on every affected area. No build-up period, no strength to work through. The common mistake is treating only the worst patches, which makes the result look worse than it is.
If It Irritates: Stinging or mild burning where you apply it settles within a week or two, and moisturizing beforehand helps. Loose stools, headache or feeling slightly sick in the first weeks is a known, usually mild effect of the drug — tell your doctor if it does not pass.
If It's Not Working: Give it 8 weeks of daily use, though itch often eases much sooner. If plaques are unchanged at 8 weeks, the options are a strong steroid for the thickest areas while keeping roflumilast on the rest, adding a vitamin D cream, or moving to light treatment or a systemic medicine. Twice a day does not help.
Twice a day, roughly 12 hours apart, with or without food — food helps some people with nausea. Swallow the tablets whole; do not crush, split or chew them.
Take it as soon as you remember, unless the next dose is close, in which case skip it. Never take two at once. If you have stopped for more than a few days, ask before restarting; the full dose brings the stomach side effects straight back, so the starter pack is usually repeated.
The absence of blood tests is why many people choose this drug. No baseline blood count, no liver panel, no tuberculosis test, no hepatitis screen, nothing repeated. Kidney function is checked once before starting, because severe impairment halves the dose.
What replaces it is clinical monitoring, which is not lighter, only different. Weight comes first. Weight loss is common and can be substantial, with some people losing five to ten percent of their body weight. If you wanted that, it is welcome. If you are older, frail or already underweight, it is a reason to reconsider, and unexplained loss should prompt a review.
Mood is second. Depression, low mood and, rarely, suicidal thoughts have been reported and appear on the label. The risk is low, but new or worsening depression should be reported promptly, and a history of depression belongs on the record before you start.
Diarrhea and nausea are third. They usually settle within the first few weeks, but severe or persistent diarrhea is not something to push through. In older adults, and in anyone on a water tablet or a blood pressure medicine, it has caused dehydration and kidney injury.
The one scheduled checkpoint is the 16-week review of skin or joints. If nothing meaningful has changed, continuing is not useful.
No routine blood tests, no boxed warning, no limit on how much body surface you treat, no maximum duration.
What is worth watching has nothing to do with skin. The oral form causes diarrhea, nausea, appetite loss and weight loss in a meaningful number of people, and has been linked to low mood and, rarely, suicidal thoughts. The cream and foam give much lower blood levels, so these are far less common — but they are on the label and your doctor will ask. If you lose weight without trying, or your mood drops, say so.
Otherwise monitoring is a review of whether it is working, around 8 weeks at first. Your doctor will check your history for liver problems, since severe liver impairment rules it out.
Approximate windows, not promises.
First doseStarting: The starter pack steps the dose up over the first week, which softens the early side effects.
Days 1 to 14Adjusting: Loose stools, nausea and headache usually start in the first week or two and settle within a month.
Weeks 2 to 4Itch: Usually the first thing to change, ahead of the plaques. Behcet's mouth ulcers settle here too, one of the faster and more reliable responses.
Weeks 4 to 8Working: The first visible change in the skin. Scale lifts before the redness fades.
Weeks 4 to 8Working: Plaques flatten, scale drops away and redness fades. Week 8 is the fair point to judge plaque psoriasis; eczema and seborrheic dermatitis declare themselves around four weeks. Thinner plaques respond faster.
Weeks 12 to 16Judge it here: In the trials roughly one in three people reached a 75 percent improvement. Scalp psoriasis responds better than thick body plaques, a common reason to choose it.
Weeks 16 to 24Psoriatic arthritis: Joint pain, swelling and tenderness improve.
Months 3 and onwardWeight and mood: Weight loss comes on gradually, so weigh yourself regularly rather than going by how clothes feel. Mood changes are uncommon but worth watching.
Months 6 and beyondNails: The slowest of all, because a nail has to grow out before improvement shows.
First few minutesApplying it: Once a day. Possible stinging where you apply it, which usually settles.
Week 1Adjusting: A few people get diarrhea, headache or mild nausea. These come from the drug rather than the skin, and are far less common with the cream than the oral version.
Weeks 1 to 2First change: Itch improves first. In seborrheic dermatitis, flaking and redness often start easing here too.
Folds, face and eyelidsWhere it stands out: These sites absorb steroids quickly and thin fast, so a once-daily option with no time limit changes how they are managed.
After clearingHolding: No thinning, so no reason to stop once skin is clear. Many people continue daily; some drop to a few times a week.
Sorted by what to do about them.
Apremilast is expensive, priced far closer to the biologics than to older oral drugs such as methotrexate or acitretin.
So insurers commonly ask that cheaper options be tried first, and prior authorization is usual. The manufacturer runs a copay assistance program, which typically helps people with commercial insurance and is not available on government plans.
What it saves is indirect: no injection supplies, no screening tests, no repeated laboratory work. That does not close the gap with a generic tablet, but it is part of the comparison.
This is the main reason people do not end up on it. Roflumilast is brand only with no generic, and a tube runs to several hundred dollars or more. Generic steroid creams cost a small fraction of that.
A prior authorization is close to routine. Most plans want to see that a topical steroid was tried and either failed or is not appropriate — the fold, face and eyelid argument usually succeeds, because those are exactly the places long-term steroid use causes harm. Some plans also want a vitamin D cream tried first. Denials are common on the first attempt and often overturned on appeal, so push back.
The manufacturer runs a copay program that can cut the cost substantially with commercial insurance, plus patient assistance for people who qualify. Terms change often. People on government insurance generally cannot use copay cards, which is a real gap.
One practical note: cost is per tube and psoriasis treatment is open-ended, so ask about the largest tube your plan will cover — the price per gram is usually better.
Correct. No monitoring schedule, no tuberculosis screen, no repeated bloodwork. Kidney function is checked once before starting, because severe impairment halves the dose.
For most people it is worst in the first two weeks and settles within a month, which is what the five-day starter pack softens. Diarrhea that is severe or lasts past a month is a reason to be reviewed.
Some people do, and some of them lose five to ten percent of their body weight. It happens gradually, so weigh yourself every few weeks rather than judging by how clothes fit.
Less effective for thick plaques — about one in three reached a seventy-five percent improvement at 16 weeks, where biologics reach much higher figures. What it offers is a tablet, no needles, no screening, no monitoring.
Low mood and depression are uncommon but on the label, and rare reports of suicidal thoughts exist. Report any new or worsening low mood promptly.
About 16 weeks for the skin, up to 24 weeks for joints. If nothing meaningful has changed, continuing is not worthwhile.
No. It blocks an enzyme called PDE4 inside inflammatory cells. It does not thin skin, which is why it can go on the face, eyelids and folds without a time limit.
There is no fixed maximum. The rule about stopping after a few weeks comes from steroid creams. Long-term daily use with regular review is normal.
Once daily is what the trials tested. Twice does not clear skin faster and makes stomach side effects more likely.
Usually not. Diarrhea, nausea and headache are listed because they can happen, and are common with the oral version used for lung disease. Blood levels from the cream and foam are much lower.
The drug is the same. The foam lets it spread through hair and over the scalp, and it is the form used for seborrheic dermatitis. The 0.3% cream is for psoriasis and the 0.15% cream for eczema.
Clearing inflammation often leaves a dark or pale patch. Not active disease, and it fades over months. It shows up more on deeper skin tones.
A common approach — a strong steroid for the thickest patches, roflumilast for the face, folds and the rest. Plan it with your doctor rather than layering both on one spot.